These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment. Liu Y; Chewchuk S; Lavigne C; Brûlé S; Pilon G; Houde V; Xu A; Marette A; Sweeney G Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E657-64. PubMed ID: 19531641 [TBL] [Abstract][Full Text] [Related]
24. Effects of chronic acarbose treatment on adipocyte insulin responsiveness, serum levels of leptin and adiponectin and hypothalamic NPY expression in obese diabetic Wistar rats. Pérez C; Fernández-Agulló T; De Solís AJ; Ros M; Andrés A; Carrascosa JM Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):256-61. PubMed ID: 18290871 [TBL] [Abstract][Full Text] [Related]
25. The role of resistin in obesity-induced insulin resistance. Haluzik M; Haluzikova D Curr Opin Investig Drugs; 2006 Apr; 7(4):306-11. PubMed ID: 16625816 [TBL] [Abstract][Full Text] [Related]
26. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome. Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636 [TBL] [Abstract][Full Text] [Related]
27. Adiponectin: an update. Guerre-Millo M Diabetes Metab; 2008 Feb; 34(1):12-8. PubMed ID: 18069030 [TBL] [Abstract][Full Text] [Related]
28. New insights into thiol-mediated regulation of adiponectin secretion. Wolf G Nutr Rev; 2008 Nov; 66(11):642-5. PubMed ID: 19019026 [TBL] [Abstract][Full Text] [Related]
29. Adiponectin: from obesity to cardiovascular disease. Antoniades C; Antonopoulos AS; Tousoulis D; Stefanadis C Obes Rev; 2009 May; 10(3):269-79. PubMed ID: 19389061 [TBL] [Abstract][Full Text] [Related]
30. Adiponectin and interleukin-6 in inflammation-associated disease. Li L; Wu LL Vitam Horm; 2012; 90():375-95. PubMed ID: 23017723 [TBL] [Abstract][Full Text] [Related]
31. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women. Drolet R; Bélanger C; Fortier M; Huot C; Mailloux J; Légaré D; Tchernof A Obesity (Silver Spring); 2009 Mar; 17(3):424-30. PubMed ID: 19219061 [TBL] [Abstract][Full Text] [Related]
33. Human obesity and insulin resistance: lessons from experiments of nature. O'Rahilly S Novartis Found Symp; 2007; 286():13-20; discussion 20-3, 162-3, 196-203. PubMed ID: 18269171 [TBL] [Abstract][Full Text] [Related]
34. Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Shetty S; Kusminski CM; Scherer PE Trends Pharmacol Sci; 2009 May; 30(5):234-9. PubMed ID: 19359049 [TBL] [Abstract][Full Text] [Related]
35. A hypothesis: adiponectin mediates anti-atherosclerosis via adventitia-AMPK-iNOS pathway. Cai XJ; Li CJ; Chen L; Rong YY; Zhang Y; Zhang M Med Hypotheses; 2008; 70(5):1044-7. PubMed ID: 17910991 [TBL] [Abstract][Full Text] [Related]
36. The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. Kadowaki T; Yamauchi T; Kubota N FEBS Lett; 2008 Jan; 582(1):74-80. PubMed ID: 18054335 [TBL] [Abstract][Full Text] [Related]